Article

Pulmonary Cutaneous Metastasis: A Case Report and Review of Common Cutaneous Metastases

Author and Disclosure Information

The literature on cutaneous metastatic disease can be difficult to interpret because of inconsistent study design and analysis among authors. Furthermore, one should be careful when reviewing the statistics in the literature, as reported patient populations tend to vary and are not representative of the whole population. However, certain trends are notable and should be reported. Diagnosis of cutaneous metastatic disease carries a grave prognosis. We describe a patient with pulmonary cutaneous metastasis and provide a review of the literature on nonmelanomatous solid tumor malignancies that most commonly have cutaneous metastases. The review will focus on epidemiology, clinical presentation, histology and immunohistochemical staining, and prognosis and management. The most common cutaneous metastasizing carcinomas—breast, lung, and colorectal cancer—also are discussed.


 

Recommended Reading

Dx of Stage III Melanomas Likely To Rise in 2010: New AJCC Staging Takes Effect Next Year
MDedge Dermatology
Mycophenolate Mofetil May Reduce SCC Risk After Transplant
MDedge Dermatology
Agent Targeting BRAF Mutations Shows Promise
MDedge Dermatology
Panel Backs Peginterferon for Stage III Melanoma
MDedge Dermatology
AAD Seal Program Off to a Slow Start
MDedge Dermatology
Hedgehog Pathway Inhibitor Helps Fight Cancer
MDedge Dermatology
AEIOU May Help Make Merkel Cell Diagnosis
MDedge Dermatology
Unexplained Changes to The Nail Warrant Biopsy
MDedge Dermatology
Circumcision and MRSA
MDedge Dermatology
Small-Diameter Melanomas: Diameter Does Not Matter [letter]
MDedge Dermatology